世界中联肾病专业委员会标准立项通知（两项）

 

       世界中医药学会联合会批准肾病专业委员会提交的《中高风险膜性肾病辨证规范与疗效评定》（SCM-C/NP 0194-2023）立项，现予通知。

       The SCM-C standard (SCM-C/NP 0194-2023) of Syndrome differentiation and efficacy evaluation criterion of medium to high risk Membranous nephropathy proposed by Specialty Committee of Nephrology of WFCMS was initiated by World Federation of Chinese Medicine Societies and were now effective.

 

 

 

 

 

       世界中医药学会联合会批准肾病专业委员会提交的《IgA肾病分期辨证规范与疗效评定指南》（SCM-C/NP 0193-2023）立项，现予通知。

       The SCM-C standard (SCM-C/NP 0193-2023) of Criteria for Differentiation of Stage of IgA Nephropathy and Evaluation of Efficacy proposed by Specialty Committee of Nephrology of WFCMS was initiated by World Federation of Chinese Medicine Societies and were now effective.